Skip to content
Independent Medical Alliance
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate
  • My Accountmy account
  • Home
    Latest Updates

    Stay up-to-date with the latest news from our fast-moving field.

    View
    Blog

    Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from IMA.

    Read Now
    In the News

    Read media coverage of IMA from around the world.

    View
  • TREATMENT
    Treatment Guidelines

    Strategies to prevent and treat COVID-19, Long COVID, RSV, Flu and Vaccine-related issues:

    • Prevention
    • Treatment
    • Long COVID Recovery
    • Vaccine Injury Prevention
    • Shedding from Vaccines
    • Long Vax Recovery

    Strategies to prevent and treat conditions like cancer, depression, insulin resistance and more:

    • Brain Health
    • Cancer Resource Hub
    • Depression & Mental Health
    • Fasting & Healthy Eating
    • Insulin Resistance
    • Sepsis
  • Resources
    Wondering where to begin?

    Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

    get started
    Patient Resources
    • Find a Provider
    • Find a Pharmacy
    • Tools & Guides
    • Testimonials
    • FAQ
    Professional Resources
    • Journal of Independent Medicine

    • Research
    • Ivermectin Facts
    • Informed Consent
    • Join the Alliance
  • Education
    About the education portal

    IMA’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

    Education on Demand

    Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from IMA (formerly FLCCC) educational programs.

    • My Content
    • Explore Courses
  • Community
    Events

    IMA hosts dynamic events that unite top experts from diverse fields for learning, sharing, and collaboration. Join us for unique in-person and virtual experiences that foster knowledge exchange and meaningful partnerships.

    • Weekly Webinar

    • Annual Conference
    Forums

    Join the discussion! IMA public and private forums are a place for the IMA community to connect without fear of censorship.

    • Forums
    Membership

    Explore IMA (formerly FLCCC) membership options for healthcare professionals and committed individuals who share a common passion and purpose. Members receive access to private forums and exclusive content and events while supporting IMA’s mission.

    • Join Now
    • Sign In
  • About
    About the IMA

    Learn about the history of IMA (formerly FLCCC), our mission and vision, and how you can get involved.

    learn more
    • Founders & Clinical Team
    • Senior Fellows
    • Contributors
    • Partners
    • Connect with Us
    • Advocacy
    • Impact Reports
    • Annual Reports
    • Support Us
    • Shop our Store
  • Search
    Search for:
  • IMA HOME
    • Latest UpdatesGet the latest updates from the FLCCC Alliance and their work on COVID-19 prevention and treatment.
    • Blog
    • In the NewsCheck out the latest in news coverage focused on the FLCCC Alliance and our members!
  • TREATMENT
    • Prevention
    • Treatment
    • Recovery
    • More Protocols
      • Brain Health
      • Cancer Resource Hub
      • Depression & Mental Health
      • Eat Well
      • Insulin Resistance
      • Sepsis Care
      • Shedding from Vaccines
  • RESOURCES
    • Journal of Independent Medicine
    • Research
    • Tools & Guides
    • Find a Provider
    • Find a Pharmacy
    • FAQ
    • Efficacy of Ivermectin
    • Join The Alliance
  • EDUCATION
    • Courses
  • COMMUNITY
    • Events
      • Annual Conference 2026
      • Weekly WebinarsJoin FLCCC’s live webinars every Wednesday at 7 pm ET for the latest updates on COVID news & treatment options. Hear from experts, get questions answered!
    • Forums
    • Membership
  • ABOUT
    • Founders & Clinical Team
    • Senior Fellows
    • IMA Contributors
    • Partners
    • Annual Reports
    • Impact Reports
    • Connect with Us
Independent Medical Alliance
  • MY ACCOUNT
  • MY FORUMS
  • MY COURSES
Search for:
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate

References

Categories

Cancer Care (474) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (13) Antidepressants (9) Ascorbic Acid (13) autoantibodies (10) autophagy (48) Breast Cancer (30) Cancer (69) Cancer Stem Cells (11) Chemotherapy (12) Colon Cancer (11) Corticosteroids (9) COVID-19 (330) COVID-19 Vaccines (8) Curcumin (14) Cytokines (13) Depression (12) Diabetes (14) Famotidine (14) Hydroxychloroquine (15) Hyperbaric Oxygen Therapy (9) Inflammation (15) intermittent fasting (14) ivermectin (53) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Pneumonia (9) quercetin (15) resveratrol (11) SARS-CoV-2 (83) Sepsis (22) spermidine (11) Spike Protein (12) Thiamine (11) Thrombosis (9) Tinnitus (12) Tumor (41) Vitamin C (30) Vitamin D (29) Zinc (12)
  • Reference: Omega 3 polyunsaturated fatyy acids suppress the development of aortic aneurysms through the inhibition of macrophage-mediated inflammation.

    Published On: April 30, 2015

    Authors: Yoshihara T, Shimada K, Fukao K, Sai E, Matsumori R, Alshahi H PMID: 25925976 DOI: 10.1253/circj.CJ-14-0471 Abstract Background: Dietary intake of ω3 polyunsaturated fatty acids (ω3-PUFAs) reduces progression of atherosclerosis and prevents future cardiovascular events. Macrophages are key players in the pathogenesis of aortic aneurysm. The effects of ω3-PUFAs on abdominal aortic aneurysm [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-RECOVER Long Covid

    Tags: Aortic Aneurysms, Omega-3

  • Reference: Novel pro-resolving lipid mediators in inflammation are leads for resolution physiology.

    Published On: December 11, 2014

    Authors: Serhan CN PMID: 24899309 PMCID: PMC4263681 doi: 10.1038/nature13479 Abstract Advances on mechanisms in resolution of acute inflammation uncovered a new genus of pro-resolving lipid mediators that include separate families of molecules: lipoxins, resolvins, protectins and maresins, collectively coined specialized pro-resolving mediators (SPM). Synthetic SPM possess potent bioactions when administered in vivo. In animal experiments, [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: Inflammation

  • Reference: The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.

    Published On: November 4, 2014

    Authors: Lucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD PMID: 25122198 PMCID: PMC4409786 DOI: 10.1158/2159-8290.CD-13-1010 Abstract TMPRSS2 is an androgen-regulated cell-surface serine protease expressed predominantly in prostate epithelium. TMPRSS2 is expressed highly in localized high-grade prostate cancers and in the majority of human prostate cancer metastases. Through the generation of mouse [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV

    Tags:

  • Reference: Isoquercitrin: Pharmacology, toxicology, and metabolism.

    Published On: May 27, 2014

    Authors: Valentova K, Vrba J, Bancirova M, Ulrichova J. PMID: 24680690 DOI: 10.1016/j.fct.2014.03.018 Abstract The flavonoid isoquercitrin (quercetin-3-O-β-d-glucopyranoside) is commonly found in medicinal herbs, fruits, vegetables and plant-derived foods and beverages. This article reviews the occurrence, preparation, bioavailability, pharmacokinetics, toxicology and biological activity of isoquercitrin and "enzymatically modified (α-glucosylated) isoquercitrin" (EMIQ). Pure isoquercitrin can now [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-PREVENT, I-RECOVER Post-Vaccine

    Tags: Isoquercitrin

  • Reference: Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.

    Published On: February 5, 2014

    Authors: Ishima T, Fujita Y, Hashimoto K PMID: 24508523 DOI: 10.1016/j.ejphar.2014.01.064 Abstract The sigma-1 receptor chaperone located in the endoplasmic reticulum (ER) may be implicated in the mechanistic action of some antidepressants. The present study was undertaken to examine whether new antidepressant drugs interact with the sigma-1 receptor chaperone. First, we examined the effects of [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV

    Tags:

  • Reference: Diverse biological activities of dandelion.

    Published On: August 17, 2012

    Authors: Gonzalez-Castejoxn M, Visioli F, Rodrigues-Casado A PMID: 22946853 DOI: 10.1111/j.1753-4887.2012.00509.x Abstract Dandelion (Taraxacum officinale Weber) is a member of the Asteraceae (Compositae) family, native to Europe but widely distributed in the warmer temperate zones of the Northern Hemisphere. Dandelion and its parts are habitually consumed as plant foods in several areas of the world, [...]

    Categories: I-CARE Flu and RSV, I-RECOVER Post-Vaccine

    Tags: biology, dandelion

  • Reference: Brazilian blood donation eligibility criteria for dermatologic patients.

    Published On: July 8, 2012

    Authors: Wambier CG, de Pina Almeida Prado Junior B, Pereira CS, Foss NT PMID: 22892774 DOI: 10.1590/s0365-05962012000400012 Abstract A focused and commented review on the impact of dermatologic diseases and interventions in the solidary act of donating blood is presented to dermatologists to better advise their patients. This is a review of current Brazilian technical [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV

    Tags:

  • Reference: Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.

    Published On: March 28, 2012

    Authors: Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A. PMID: 22470478 PMCID: PMC3314669 DOI: 10.1371/journal.pone.0033805 Abstract Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and TNF. Contact dermatitis and photosensitivity are skin conditions that involve [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-PREVENT, I-RECOVER Post-Vaccine

    Tags: Cromolyn, Mast Cells, quercetin

  • Reference: Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.

    Published On: October 17, 2011

    Authors: Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Arroyo V, Claria J PMID: 22013115 DOI: 10.4049/jimmunol.1100225 Abstract We recently demonstrated that ω-3-polyunsaturated fatty acids ameliorate obesity-induced adipose tissue inflammation and insulin resistance. In this study, we report novel mechanisms underlying ω-3-polyunsaturated fatty acid actions on adipose tissue, adipocytes, and stromal vascular cells (SVC). [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-RECOVER Long Covid

    Tags: Docosahexaenoic Acid, Resolvin D1

  • Reference: Decreased serotonin content and reduced agonist-induced aggregation in platelets of chronically medicated with SSRI drugs.

    Published On: September 4, 2011

    Authors: Bismuth-Evenzal Y, Gonopolsky Y, gurwitz D, Iancu I, Weizman A PMID: 21893349 DOI: 10.1016/j.jad.2011.08.013 Abstract Background: Chronic treatment with selective serotonin reuptake inhibitors (SSRIs) reduces the risk and severity of cardiovascular diseases. SSRIs block the serotonin transporter, thereby inhibiting serotonin (5-HT) uptake into presynaptic neurons as well as into platelets [...]

    Categories: I-CARE Early Covid, I-CARE Flu and RSV

    Tags:

Previous234Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the IMA
  • Protocols

  • Providers

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us
FLCCC Logo with white letters
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About IMA
  • Protocols
  • Providers
  • Testimonials
  • Latest Updates
  • Newsletter Signup
Support Us
Give Now
shop
Follow Us
Disclaimer

©2020–2025 All Rights Reserved Independent Medical Alliance (IMA), formerly FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. IMA does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “IMA”, I agree and acknowledge that “IMA” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For information on data handling, terms of use, and disclaimers, visit our Privacy Policy & Terms.

© Copyright 2026. Independent Medical Alliance (IMA), formerly FLCCC Alliance.

Page load link
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT

Ask Our Experts

Have a question you don’t see on our list? Complete the form below with a question or topic you’d like our experts to consider adding to our FAQs resource center. Questions will not be answered individually (we cannot provide medical advice or treatment through this form).

Please enable JavaScript in your browser to complete this form.
Opt In
Loading

Disclaimer: We are unable to offer individualized medical advice, diagnoses, or treatment recommendations. For any personal medical decisions, always consult with your own healthcare provider.

Join us at IMA 2026

This year’s IMA Medical Education Conference is a two-day event in Texas covering the latest innovations, research, and forward-thinking practices shaping the future of healthcare.

Buy Tickets Now

Early Bird Pricing Ends January 31st!

0
0
0
0
Days
0
0
Hrs
0
0
Min
0
0
Sec

Go to Top